Stocks CRWD Financial statements
Financial statementsCrowdStrike Holdings, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data CrowdStrike Holdings, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 119 | 250 | 481 | 874 | 1,452 | 2,241 | 3,056 | 3,954 | 4,812 |
| Cost of revenue | 54.5 | 87.2 | 142 | 230 | 383 | 601 | 759 | 990 | 1,219 |
| Gross profit | 64.3 | 163 | 340 | 645 | 1,068 | 1,640 | 2,297 | 2,963 | 3,593 |
| Research and development | 58.9 | 84.6 | 130 | 215 | 371 | 608 | 780 | 1,076 | 1,385 |
| Selling and marketing | 104 | 173 | 267 | 401 | 617 | 904 | 1,140 | 1,523 | 1,831 |
| General and administrative | 32.5 | 42.2 | 89.1 | 121 | 223 | 317 | 395 | 481 | 670 |
| Operating expenses | 196 | 299 | 486 | 737 | 1,211 | 1,830 | 2,316 | 3,080 | 3,886 |
| Operating income | -131 | -137 | -146 | -92.5 | -143 | -190 | -19.1 | -116 | -293 |
| Interest expense | 1.65 | 0.43 | 0.44 | 1.56 | 25.2 | 25.3 | 25.8 | 26.3 | 28 |
| Interest income | 52.5 | 149 | 196 | 195 | |||||
| Other non-operating income | -1.47 | -1.42 | 6.73 | 1.25 | 3.97 | 3.05 | 1.64 | 5.1 | -0.65 |
| Pre-tax income | -135 | -139 | -140 | -87.9 | -160 | -160 | 106 | 58.6 | -127 |
| Income tax | 0.93 | 1.37 | 2 | 4.76 | 72.4 | 22.4 | 32.2 | 71.1 | 34.2 |
| Net income to minority interests | 0 | 0 | 2.42 | 0.96 | 1.26 | 2.68 | 1.34 | ||
| Net income | -135 | -140 | -142 | -92.6 | -235 | -183 | 72.2 | -15.2 | -163 |
| EPS, basic | -2.74 | -2.53 | -0.78 | -0.35 | -0.84 | -0.64 | 0.30 | -0.06 | -0.65 |
| EPS, diluted | -2.74 | -2.53 | -0.78 | -0.35 | -0.84 | -0.64 | 0.30 | -0.06 | -0.65 |
| Shares, basic (weighted) | 51.6 | 55.3 | 183 | 269 | 280 | 288 | 239 | 245 | 251 |
| Shares, diluted (weighted) | 51.6 | 55.3 | 183 | 269 | 280 | 288 | 244 | 245 | 251 |
Balance sheet
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 63.2 | 88.4 | 265 | 1,919 | 1,997 | 2,455 | 3,375 | 4,323 | 5,230 |
| Short-term investments | 103 | 647 | 0 | 0 | 250 | 99.6 | 0 | ||
| Receivables | 92.5 | 165 | 239 | 368 | 626 | 853 | 1,129 | 1,362 | |
| Other current assets | 1.11 | 6.52 | 4.57 | 12.8 | 122 | 38.3 | 67.1 | 129 | |
| Total current assets | 331 | 1,172 | 2,292 | 2,571 | 3,640 | 4,757 | 6,113 | 7,419 | |
| Property, plant and equipment | 73.7 | 136 | 167 | 261 | 492 | 620 | 789 | 976 | |
| Lease right-of-use assets | 0 | 36.5 | 31.7 | 39.9 | 48.2 | 42.8 | 69.9 | ||
| Goodwill | 7.95 | 7.72 | 83.6 | 416 | 431 | 638 | 913 | 1,363 | |
| Intangible assets | 1.05 | 0.53 | 15.7 | 97.3 | 86.9 | 115 | 133 | 137 | |
| Other non-current assets | 9.18 | 16.7 | 17.1 | 25.3 | 29 | 76.1 | 137 | 389 | |
| Total assets | 433 | 1,405 | 2,733 | 3,618 | 5,027 | 6,647 | 8,702 | 11,087 | |
| Accounts payable | 6.86 | 1.35 | 12.1 | 47.6 | 45.4 | 28.2 | 131 | 105 | |
| Accrued liabilities | 32.5 | 30.4 | 51.1 | 83.4 | 138 | 126 | 191 | 181 | |
| Deferred revenue | 219 | 413 | 702 | 1,137 | 1,727 | 2,271 | 2,733 | 3,421 | |
| Total current liabilities | 281 | 493 | 864 | 1,407 | 2,109 | 2,697 | 3,461 | 4,184 | |
| Long-term debt | 0 | 738 | 740 | 741 | 742 | 744 | 745 | ||
| Lease liabilities | 0 | 32 | 25.4 | 29.6 | 36.2 | 31.1 | 56.4 | ||
| Other non-current liabilities | 10.3 | 11 | 17.2 | 16.2 | 31.8 | 50.1 | 151 | 296 | |
| Total liabilities | 363 | 662 | 1,861 | 2,581 | 3,539 | 4,309 | 5,383 | 6,614 | |
| Total debt | 0 | 738 | 740 | 741 | 742 | 744 | 745 | ||
| Paid-in capital | 31.2 | 1,378 | 1,598 | 1,992 | 2,613 | 3,364 | 4,410 | 5,694 | |
| Retained earnings | -519 | -637 | -730 | -965 | -1,148 | -1,059 | -1,121 | -1,283 | |
| Other comprehensive income | 0.1 | 1.01 | 2.32 | -1.24 | -1.02 | -1.66 | -9.59 | 16.8 | |
| Shareholders' equity | -369 | -488 | 742 | 871 | 1,026 | 1,464 | 2,304 | 3,279 | 4,428 |
| Minority interests | 0 | 0.5 | 1.3 | 11.9 | 23.8 | 33.1 | 39.4 | 44.2 | |
| Total equity | -369 | -488 | 743 | 872 | 1,038 | 1,487 | 2,337 | 3,319 | 4,473 |
| Total liabilities and equity | 433 | 1,405 | 2,733 | 3,618 | 5,027 | 6,647 | 8,702 | 11,087 | |
| Shares outstanding | 58.5 | 0 |
Cash flow statement
| FY2018 | FY2020 | FY2020 | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Net income | -135 | -140 | -142 | -92.6 | -232 | -182 | 73.4 | -12.6 | -161 |
| Stock-based compensation | 12.3 | 20.5 | 79.9 | 150 | 310 | 527 | 649 | 861 | 1,097 |
| Deferred income tax | -0.11 | -0.42 | -0.68 | -1.45 | -14 | 1.31 | -3.39 | -9.9 | -14.8 |
| Change in receivables | -35.3 | -33.4 | -72.5 | -73 | -125 | -258 | -218 | -274 | -233 |
| Change in payables | 7.14 | -2.4 | -6.57 | 11.3 | 33.2 | -15.5 | -18.9 | 84.9 | -11.3 |
| Cash from operations | -58.8 | -23 | 99.9 | 357 | 575 | 941 | 1,166 | 1,382 | 1,612 |
| Capital expenditures | -22.9 | -35.9 | -80.2 | -52.8 | -112 | -235 | -177 | -255 | -302 |
| Acquisitions | -6.47 | 0 | 0 | -85.5 | -415 | -18.3 | -239 | -310 | -382 |
| Purchases of investments | -9.56 | -199 | -780 | -84.9 | 0 | -250 | -196 | 0 | 0 |
| Sales and maturities of investments | 17.5 | 100 | 229 | 91.6 | 0 | 0 | |||
| Cash from investing | -28.3 | -142 | -630 | 495 | -565 | -557 | -341 | -537 | -764 |
| Debt repaid | -19.3 | -6.16 | 0 | 0 | |||||
| Stock issued | 3.7 | 3.91 | 21.5 | 28.8 | 15.9 | 8.66 | 8.7 | 3.98 | 3.16 |
| Share buybacks | 0 | -2.33 | 0 | 0 | |||||
| Cash from financing | 127 | 190 | 706 | 800 | 72.5 | 77.4 | 93.2 | 107 | 132 |
| Exchange rate effect | 0.62 | -0.16 | -0.07 | 1.68 | -4.77 | -1.5 | 1.96 | -5.28 | 9.63 |
| Net change in cash | 40.4 | 25.2 | 176 | 1,654 | 78 | 460 | 921 | 947 | 990 |
| Free cash flow | -81.7 | -58.8 | 19.7 | 304 | 463 | 706 | 990 | 1,127 | 1,310 |
| Interest paid | 1.65 | 0.45 | 0.01 | 0.02 | 13.1 | 22.6 | 22.5 | 22.5 | 22.5 |
| Income taxes paid | 0.11 | 1.39 | 1.86 | 1.73 | 74.7 | 11.9 | 22.6 | 19 | 51.5 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 75.2% | Gross profit / revenue. |
| Operating margin | -2.5% | Operating income / revenue. |
| Pre-tax margin | 1.4% | Pre-tax income / revenue. |
| Net margin | 0.8% | Net income / revenue. |
| FCF margin | 29.8% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 37.4% | Cash from operations / revenue. |
| Effective tax rate | -1.5% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 0.9% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 0.4% | Net income / average total assets. |
| Return on invested capital (ROIC) | -12.6% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 28.8% | Research and development expense / revenue. |
| Stock-based pay / revenue | 22.8% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 7.6% | Capital expenditures / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 21.7% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 29.0% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 40.6% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 21.2% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 29.9% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 41.0% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 16.7% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 19.7% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 35.2% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 16.3% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 22.9% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 34.0% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 35.0% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 44.6% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 38.4% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 27.4% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 30.2% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 32.3% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 2.4% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -4.5% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -1.4% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.57x | Current assets / current liabilities. |
| Quick ratio | 1.37x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.13x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.15x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 6.2% | Total debt / total assets. |
| Liabilities / assets | 57.3% | Total liabilities / total assets. |
| Net debt | -$4.27B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Interest coverage | -4.99x | Operating income / interest expense. |
| Working capital | $2.53B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 21.0% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $2.58B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.45x | Revenue / average total assets. |
| Fixed asset turnover | 4.59x | Revenue / average property, plant and equipment. |
| Receivables turnover | 5.20x | Revenue / average receivables. |
| Days sales outstanding | 70 days | 365 x average receivables / revenue. |
| Days payables | 31 days | 365 x average accounts payable / cost of revenue. |
| FCF conversion | 3,575.0% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 20.2% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.04 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $5.17 | Revenue / diluted weighted shares. |
| FCF per share | $1.54 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $1.93 | Cash from operations / diluted weighted shares. |
| Book value per share | $4.88 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $2.47 | Tangible book value / shares outstanding. |
| Cash per share | $4.80 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $256.73B | Share price x shares outstanding. |
| Enterprise value | $252.47B | Market cap + total debt - cash - short-term investments. |
| P/E | 5,706x | Market cap / net income. Only when net income is positive. |
| P/S | 47.6x | Market cap / revenue. |
| P/B | 50.3x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 99.6x | Market cap / tangible book value, when positive. |
| P/FCF | 160x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 127x | Market cap / cash from operations, when positive. |
| EV/Sales | 46.8x | Enterprise value / revenue. |
| EV/FCF | 157x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 0.6% | Free cash flow / market cap. |
| Earnings yield | 0.0% | Net income / market cap (the inverse of P/E). |
What was CrowdStrike Holdings, Inc.'s revenue in fiscal 2026?
CrowdStrike Holdings, Inc. reported revenue of $4.81B for fiscal 2026, 21.7% higher than the year before.
Was CrowdStrike Holdings, Inc. profitable in fiscal 2026?
No. It reported a net loss of $162.5M.
How much free cash flow did CrowdStrike Holdings, Inc. generate in fiscal 2026?
Cash from operations of $1.61B minus capital expenditures of $302.1M left free cash flow of $1.31B.